Correction to “Significance of Mutation Spots and Concurrent Gene Mutations on Prognosis and Clinical Outcomes in Myelodysplastic Syndromes with SF3B1 Mutation”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAcute Myeloid Leukemia Research · Myeloproliferative Neoplasms: Diagnosis and Treatment · Hematological disorders and diagnostics
Liu Q, Xu F, Guo J, et al. Significance of mutation spots and concurrent gene mutations on prognosis and clinical outcomes in myelodysplastic syndromes with SF3B1 mutation. Cancer Medicine, 2025; 14:e70930.
On the seventh line of the “Targeted Gene Sequencing” section, the word “cDNA” was incorrect. This should have read: “gDNA.”
We apologize for this error.